Intelligent Diagnosis and Treatment Model for Insomnia Disorder

NCT06375447 · tracked via the Priya Life Science China tracker

Sponsor

Xuanwu Hospital, Beijing

Phase

Observational

Started

2022-12-01

Last updated

2024-12-10

Condition(s) studied

Insomnia

Investigational drug(s) / intervention(s)

Routine clinical treatment

Routine clinical treatment: Routine clinical treatment is based on the latest international guidelines for insomnia.

Study summary

To establish a multicenter, multi-dimensional cohort on insomnia disorder and to develop an intelligent model for the diagnosis and treatment of insomnia disorder.

Eligibility

Sex

ALL

Min age

18 Years

Max age

75 Years

Healthy volunteers

Inclusion Criteria: 1. A complaint of insomnia; 2. Age between 18 and 75; 3. Able to fill out the scale on their own; 4. Agree to sign the informed consent to participate in the study and cooperate in completing the follow-up visit. Exclusion Criteria: 1.A current or history of comorbid Axis I psychiatric disorders.

Primary outcome measure(s)

The change of Pittsburgh Sleep Quality Index (PSQI) total scores from baseline to 3 months, 6 months, 12 months, 18 months, and 24 months. — Baseline, 3 months, 6 months, 12 months, 18 months, 24 months
The PSQI consists of 7 factors ranging from 0 to 3 points, and the total score ranges from 0 to 21 with higher scores indicating poorer quality.

Trial sites (5)

Facility	City	Region	Status
Xuanwu Hospital, Capital Medical University	Beijing	China	Recruiting
Beijing Tiantan Hospital, Capital Medical University	Beijing	China	Recruiting
The First Bethune Hospital of Jilin University	Changchun	China	Not Yet Recruiting
West China Hospital, Sichuan University	Chengdu	China	Recruiting
The Second Affiliated Hospital of Soochow University	Suzhou	China	Not Yet Recruiting

More Xuanwu Hospital, Beijing trials in China

Investigator Initiated Trial of Galcanezumab Treatment in Alzheimer's Disease Recruiting

DBS for Treatment-resistant Obsessive-compulsive Disorder Starting soon

The Safety and Efficacy Evaluation of Everolimus as an Adjunctive Treatment for Focal Refractory Epilepsy Recruiting

Efficacy of Probucol Combined with Statins Treatment for Ischemic Stroke Recruiting

Exploring DBS Efficacy in Treatment-refractory Tourette's Syndrome Starting soon

Other trials for the same condition

A Study of Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) for Insomnia During Pregnancy Active, not recruiting

Changes in Etomidate Dosage in Patients With Insomnia Undergoing Intravenous Anesthesia Recruiting

Artificial Intelligence (AI)-Assisted Sleep Intervention for Insomnia in Older Adults With Subjective Cognitive Decline Starting soon

Clinical Efficacy and Health Economic Evaluation of an Intelligent Diagnostic and Treatment Model Recruiting

Efficacy of Acupuncture Treatment for Breast Cancer-associated Insomnia Active, not recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06375447 on ClinicalTrials.gov ↗ ← All trials in China